Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
European Urology Open Science|October 3, 2022
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based DataEugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, et al.
JAMA Network Open|August 8, 2022
Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With DiabetesE Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2026
Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in SwedenArmando Galdieri, Hans Garmo, Rolf Gedeborg, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Breast Cancer Research : BCR|January 24, 2020
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohortAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
International Journal of Cancer|December 15, 2015
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort studyFrederik B Thomsen, Yasin Folkvaljon, Hans Garmo, et al.
Scandinavian Journal of Urology|February 4, 2026
Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancerEugenio Ventimiglia, Marcus Westerberg, Paolo Zaurito, et al.
The British Journal of Surgery|April 21, 2026
Comparing multifocality to unifocal breast cancer and the relation to survival: a national cohort studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Prognostic markers under watchful waiting and radical prostatectomyLars Holmberg, Anna Bill-Axelson, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
PCBaSe Sweden: a register-based resource for prostate cancer researchEva Hagel, Hans Garmo, Anna Bill-Axelson, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
European Urology Open Science|October 3, 2022
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based DataEugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, et al.
JAMA Network Open|August 8, 2022
Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With DiabetesE Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2026
Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in SwedenArmando Galdieri, Hans Garmo, Rolf Gedeborg, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Breast Cancer Research : BCR|January 24, 2020
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohortAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
International Journal of Cancer|December 15, 2015
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort studyFrederik B Thomsen, Yasin Folkvaljon, Hans Garmo, et al.
Scandinavian Journal of Urology|February 4, 2026
Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancerEugenio Ventimiglia, Marcus Westerberg, Paolo Zaurito, et al.
The British Journal of Surgery|April 21, 2026
Comparing multifocality to unifocal breast cancer and the relation to survival: a national cohort studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Prognostic markers under watchful waiting and radical prostatectomyLars Holmberg, Anna Bill-Axelson, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
PCBaSe Sweden: a register-based resource for prostate cancer researchEva Hagel, Hans Garmo, Anna Bill-Axelson, et al.
Pageof 27